
CPE
Description
CPE, formerly known as CITIC Private Equity Funds Management, stands as a leading private equity firm in China, operating as the strategic onshore private equity platform of the vast CITIC Group. Established in 2008, CPE has rapidly grown to become a formidable force in the Chinese investment landscape, managing a substantial portfolio across various funds. The firm's investment strategy primarily focuses on growth equity and buyout opportunities within China, targeting sectors critical to the nation's economic transformation and consumption upgrade.
CPE's investment philosophy centers on long-term value creation, leveraging its deep industry insights, extensive network, and the robust resources of the CITIC Group. The firm is particularly active in high-growth sectors such as healthcare, advanced manufacturing, new consumption, and technology. They seek to partner with exceptional management teams, providing not just capital but also strategic guidance and operational support to help portfolio companies achieve sustainable growth and market leadership. Their approach often involves taking significant minority stakes or control positions in established companies with strong fundamentals and growth potential.
With an impressive asset under management (AUM) exceeding $20.7 billion as of December 2023, CPE has demonstrated its capacity to deploy significant capital into large-scale transactions. The firm has a strong track record of successful investments and exits, contributing to the development of key industries in China. Their disciplined investment process and commitment to post-investment value addition underscore their position as a preferred partner for companies seeking strategic capital for expansion and transformation.
Investor Profile
CPE has backed more than 34 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 26% of its total and boasts 25 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series D rounds (top funding stages).
- Majority of deals are located in China, United States, Hong Kong.
- Strong thematic focus on Health Care, Artificial Intelligence (AI), Transportation.
- Typical check size: $50M – $350M.
Stage Focus
- Series C (24%)
- Series B (15%)
- Series D (15%)
- Private Equity (15%)
- Series A (12%)
- Series E (9%)
- Series Unknown (6%)
- Series G (3%)
- Series F (3%)
Country Focus
- China (91%)
- United States (6%)
- Hong Kong (3%)
Industry Focus
- Health Care
- Artificial Intelligence (Ai)
- Transportation
- Biotechnology
- Autonomous Vehicles
- E-commerce
- Public Transportation
- Manufacturing
- Robotics
- Medical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.